Privately owned company focusing on fermentation technologies, with production and recovery for cholesterol-lowering and alpha-glucosidase inhibitor drugs. Based in Calgary Alberta, Canada.
Focused on the discovery and commercialization in the fields of reproduction and development, applying gene technologies to human and veterinary biotherapeutics. Ordering information for embryonic stem cells, manufacture of recombinant proteins, such as equine somatotropin, in Thebarton, South Australia.
Conglomerate industrial group, with more than 20 subsidiaries, engaged in the field of pharmaceutical production and manufacturers of recombinants, especially human insulin in Shanghai, China.
Products targeted on rare inherited disorders, kidney disease, orthopaedics, transplant and immune disease, cancer, and diagnostic testing. Includes links to global subsidiaries, headquartered from Cambridge, Massachusetts (Nasdaq: GENZ)
Discovers and develops drugs targeting skeletal, endocrinological, gastrointestinal, and central nervous system. Includes glossary, stages in pipeline, careers in North America, and investment in Salt Lake City, Utah. (Nasdaq: NPSP).
Privately held company developing therapies for hemophilia and other genetic disorders, using recombinant Factor VIII and gene therapy. Includes clinical trial status, licensing, corporate profile and contacts in Bala Cynwyd, Pennsylvania.
Develops and commercializes innovative products for the treatment of melanoma, prostate cancer, viral diseases, including HIV. Information for investors, and details of the company in Tarrytown, New York. (Nasdaq: PGNX)
Researches, develops, manufactures and markets synthetic version of protein A for monoclonal antibody processing, and peptides such as secretin for gastrointestinal and pediatric neurology. Details for investors and clinical programs run from Waltham Massachusetts. (Nasdaq: RGEN)
Develops and markets products targeted for treatment of cancer and diseases such as hepatitis B and C, cystic fibrosis and immune system disorders. Based in San Mateo, California. (Nasdaq: SCLN)
Specializing in multiple sclerosis, fertility, growth therapies and AIDS wasting. Includes company history and milestones. Includes products, pipeline, investor and media details, with headquarters in Geneva, Switzerland. (NYSE: SRA)
Business /
Biotechnology_and_Pharmaceuticals /
Pharmaceuticals /
Manufacturing
|